Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors

Published:2022-05 Issue:5 Volume:30 Page:2005-2023
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Becker Jonas^ORCID,Stanifer Megan Lynn^ORCID,Leist Sarah Rebecca^ORCID,Stolp Bettina^ORCID,Maiakovska Olena^ORCID,West Ande^ORCID,Wiedtke Ellen,Börner Kathleen,Ghanem Ali^ORCID,Ambiel Ina,Tse Longping Victor^ORCID,Fackler Oliver Till^ORCID,Baric Ralph Steven^ORCID,Boulant Steeve^ORCID,Grimm Dirk^ORCID

Funder

NIH

Deutsches Zentrum fur Infektionsforschung eV

Deutsche Forschungsgemeinschaft

Bundesministerium fur Bildung Wissenschaft und Forschung

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference83 articles.

1. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N. Engl. J. Med.,2020

2. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia;Logunov;Lancet,2021

3. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine;Polack;N. Engl. J. Med.,2020

4. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey;Lancet,2021

5. Development of vaccines and antivirals for combating viral pandemics;Pardi;Nat. Biomed. Eng.,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the effect of RNA secondary structure on Cas13d-mediated target RNA cleavage;Molecular Therapy - Nucleic Acids;2024-09

2. The mutational landscape of SARS-CoV-2 provides new insight into viral evolution and fitness;2024-07-03

3. Development of a highly stable, active small interfering RNA with broad activity against SARS-CoV viruses;Antiviral Research;2024-06

4. RNAi-mediated inhibition of SARS-CoV-2: applications and challenges;Future Virology;2024-03-03

5. Highly Potent Antisense Oligonucleotides Locked Nucleic Acid Gapmers Targeting the SARS-CoV-2 RNA Genome;Nucleic Acid Therapeutics;2023-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3